Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate Open-Label Extension for Partial Onset Seizures
NCT00744731Phase 3Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Jan 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of carisbamate in focal onset seizure, sponsored by SK Life Science, Inc.. Started Jan 2009; status: completed.
02
Drugs
carisbamate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00744731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744731.